SummaryRMgm-5249
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 36040030 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Ambekar, SV, Mair GR |
Name Group/Department | Biomedical Sciences, |
Name Institute | Iowa State University |
City | Ames |
Country | USA |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5249 |
Principal name | PBANKA_0609700 |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Diffuse cytoplasmic location in blood stages |
Gametocyte/Gamete | Not tested |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Protein (function) and Phenotype Additional information Other mutants
|
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0609700 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1211200 | ||||||||||||||||||||||||||
Gene product | conserved Plasmodium protein, unknown function | ||||||||||||||||||||||||||
Gene product: Alternative name | |||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For comparison of various biotin ligases, nucleoporin 138 (Nup138) was used as the bait protein. The C-terminal region of the gene was PCR-amplified from P. berghei genomic DNA using Q5 High-Fidelity DNA polymerase. BioID2-3XHA was obtained from Addgene (#74224) and was fused in-frame to the C-terminal end of the Nup138 resulting in plasmid pLIS0574 which also contains the Toxoplasma gondii DHFR selection marker. Each Nup138 tagging construct includes a 1,848 bp fragment encoding the C-terminal region of the 3,714 bp long gene to promote homologous recombination. Similarly, another fusion protein plasmid was made with the same bait protein but with a 13X GGGGS linker between the C-terminus of the protein and BioID2. TurboID-3XHA (Addgene #107171) was fused in-frame to the C-terminal end of the Nup138 using the plasmid pLIS0574; likewise mini-TurboID-3XHA (Addgene #107172) and BirA* (12). As a wild-type control, we used the 2.34 P. berghei clone containing none of the biotin ligases. To ensure that the nuclear periphery-specific signal was from the biotin ligase fused to Nup138, we constructed a plasmid with the promoter sequence of Nup138 and TurboID as a negative control. All cloning was carried out either with T4 DNA ligase or NEBuilder HiFi (NEB). To tag all additional FG-Nups with TurboID, we replaced the Nup138 flank in pLIS0654 with flanks for the respective genes by amplifying the C-terminal regions from the genomic locus. For visualization of candidate-Nups identified via mass spectrometry, we used pLIS0010 to tag each protein with GFP. For nup434::turboID-ha, we replaced the gene flank using pLIS0654. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |